2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma
American Journal of Hematology · 2023-11 · 98 (11) · 1791-1805
DOI: 10.1002/ajh.27075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Hematology, online erschienen am 30.08.2023. Verfasst von Montreh Tavakkoli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Abstract (Originalsprache)
Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous disease with varying clinical outcomes. Our understanding of its molecular makeup continues to improve risk stratification, and artificial‐intelligence and ctDNA‐based analyses have the potential to enhance risk assessment and disease monitoring. R‐CHOP and Pola‐R‐CHP are used in the frontline setting; chimeric antigen receptor therapy (CART) is now the new standard‐of‐care for most with primary refractory disease; both CART and autologous stem cell transplantation are utilized in the relapsed and refractory setting. In this review, we summarize the classification and management of DLBCL with an emphasis on recent advances in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Stefan K Barta
Zitieren
APA
Tavakkoli, M., & Barta, S. K. (2023). 2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma. American Journal of Hematology, 98(11), 1791-1805. https://doi.org/10.1002/ajh.27075
Vancouver
Tavakkoli M, Barta SK. 2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma. American Journal of Hematology. 2023;98(11):1791-1805. doi:10.1002/ajh.27075
BibTeX
@article{Tavakkoli2023,
author = {Tavakkoli, Montreh and Barta, Stefan K},
title = {2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma},
journal = {American Journal of Hematology},
year = {2023},
volume = {98},
number = {11},
pages = {1791--1805},
doi = {10.1002/ajh.27075}
}
EUVIMED